Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
11. October 2024

Towards a New Classification of MI (This Week in Cardiology, by Dr. John Mandrola)

Smartphone showing This Week in Cardiology podcast episode from October 11, 2024, discussing a new classification of myocardial infarction from STEMI/NSTEMI to Occlusion MI

About the Podcast

This Week in Cardiology is hosted by Dr. John Mandrola, a practicing cardiologist and writer, known for sharp insights into clinical research and evolving paradigms in cardiovascular medicine. The podcast highlights evidence that challenges long-held dogma and impacts real-world care.

Summary of the Episode

In this episode, Dr. Mandrola reviews a JACC Advances state-of-the-art paper questioning the long-standing STEMI/NSTEMI classification and proposing a shift to Occlusion MI (OMI) vs non-OMI.

  • Roughly half of patients with acutely occluded coronary arteries do not show ST elevation on ECG.
  • Nearly 1 in 3 NSTEMI patients actually have an occlusion and could benefit from emergent PCI.
  • The current paradigm hides false negatives — patients with occlusion but without ST elevation are mislabeled as NSTEMI, delaying life-saving treatment.
  • Authors propose four steps:
    1. Change the language to OMI vs non-OMI.
    2. Update the medical record to reflect OMI vs non-OMI.
    3. Transition “code STEMI” to “code OMI.”
    4. Improve early diagnosis in prehospital and ED settings using AI, ECG expertise, and point-of-care ultrasound.
  • Dr. Mandrola stresses that AI tools like PMcardio Queen of Hearts™ and better ECG education can help identify subtle occlusions often missed under the old paradigm.

“This may be the most important topic I’ve covered in a long time: OMI, not STEMI or NSTEMI. It’s time for a Kuhn-like scientific revolution.”
— Dr. John Mandrola, This Week in Cardiology

🎧 Listen to the episode: Official page | Spotify | Apple Podcasts

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

Share this article

Don't miss these

Powerful Medical team receiving the MedTech Innovator 2025 Mid-Stage Grand Prize award on stage, holding a large winner’s check.

Powerful Medical Wins MedTech Innovator 2025

Powerful Medical has been named MedTech Innovator 2025, winning MTI’s Mid-Stage Grand Finals—top honor from the world’s largest medtech accelerator. The award recognizes PMcardio and its FDA Breakthrough-designated Queen of Hearts™ AI ECG technology, which doubles sensitivity for detecting severe heart attacks and significantly cuts ECG-to-balloon time in large clinical trials.

PMcardio Reports Positive RCT Results and Late-Breaking Clinical Science for STEMI Detection

PMcardio’s AI-powered ECG technology delivers breakthrough results at TCT 2025—improving heart attack detection, reducing false activations, and enabling faster treatment across major clinical trials, including the landmark DIFOCCULT-3 RCT.

Join over 100,000 healthcare professionals who are already taking advantage of AI

Discover the future of medical work with us.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.